VIVO News and Press, Meridian Bioscience Inc.

Net revenue for Q4 2022 was $7.1 million, a 15% increase from prior quarter. Net revenue for 2022 was $25.4 million, a 2% increase compared to 2021. Net losses have decreased by 21.2 million in 2022, a 30% decrease from the prior year. The Company signed a definitive agreemen...

Toronto, Ontario--(Newsfile Corp. - March 24, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that it has obtained a final court order (the " Final Order ") from the Ontario Superior Court of Justice (Commercial List) approving the previously announced pl...

Toronto, Ontario--(Newsfile Corp. - March 21, 2023) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) (" VIVO ") is pleased to announce that, at the special meeting of the shareholders of VIVO (the " Shareholders ") held today (the " Meeting "), the Shareholders approved (i) a special resolutio...

SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian Bioscience PR Newswire CINCINNATI and SEOUL, South Korea , Jan. 31, 2023 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solu...

DoubleVerify Holdings to Join S&P SmallCap 600 DoubleVerify Holdings to Join S&P SmallCap 600 PR Newswire NEW YORK , Jan. 25, 2023 /PRNewswire/ -- DoubleVerify Holdings Inc. (NYSE: DV) will replace Meridian Bioscience Inc. (NASD: VIVO) in the S&P ...

Summary Meridian Biosciences released an update saying it set the closing date for its merger on Jan. 31. The stated reason is that the acquiring parties wanted some extra time to get the financing. The parties waived a Jan. 6 termination date and otherwise there doesn't appear to b...

Meridian Bioscience ( NASDAQ: VIVO ) rose 8% after it said its planned sale to SD Biosensor, SJL Partners is expected to close on Jan. 31. Meridian ( VIVO ) and the buyer group agreed to consummate the deal on Jan. 31 and  to waive their right to terminate the merger agre...

MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTS PR Newswire CINCINNATI , Nov. 22, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year...

Most investors would like to see their stock portfolio grow significantly, especially if they have quite a few years left until retirement. Moreover, savvy investors would search for such growth without the associated risks involved with investing in speculative stocks. Alphabet (...

NEW YORK, NY / ACCESSWIRE / September 22, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Aerie Pharmaceuticals, Inc. (NA...